Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Dermatology

Beyond Hair Loss: Nails and Related Health Conditions

At a Glance

Alopecia Universalis is a systemic autoimmune condition that affects more than just hair. It frequently causes nail changes like pitting and brittleness, and increases the risk for other autoimmune diseases like thyroid issues, making regular health check-ups essential.

While the most visible sign of Alopecia Universalis (AU) is the total loss of body hair, this condition is a systemic (body-wide) autoimmune process. Because the immune system is hyper-focused on attacking the hair follicles, it can sometimes affect other parts of the body or indicate that other systems are also under stress [1][2]. Understanding these “invisible” symptoms can help you and your care team manage your health more effectively.

The “Twenty-Nail Dystrophy” and Other Nail Changes

For many people with AU, the immune system also targets the nails. These changes are often used by doctors as a marker of how severe the underlying autoimmune activity is [3]. Common nail symptoms include:

  • Pitting: Small, shallow dents or “pits” on the surface of the fingernails or toenails [3][4].
  • Trachyonychia: Also known as twenty-nail dystrophy, this makes the nails appear rough, thin, and brittle, often resembling the texture of sandpaper [3][5].
  • Red Spots: Small red spots on the lunula (the white, half-moon shape at the base of your nail) can sometimes predict a more severe course of hair loss [3].
  • Brittleness: Nails may split or break more easily than they did before the onset of AU [5].

Common Autoimmune Connections

AU rarely exists in a vacuum. Because it involves a breakdown in the body’s ability to recognize “self” from “nonself,” patients with AU are at a higher risk for other autoimmune conditions [1][2].

The most frequent connection is with Hashimoto’s thyroiditis (autoimmune hypothyroidism). Because this is so common, many specialists recommend regular screening for thyroid-stimulating hormone (TSH) and thyroid antibodies [2][6]. Other conditions that share similar biological pathways with AU include:

  • Vitiligo: A condition where the skin loses its pigment, causing white patches [7][8].
  • Psoriasis: An immune-mediated skin disease that causes itchy, scaly patches [2][6].
  • Celiac Disease: An immune reaction to eating gluten that can affect nutrient absorption [2][6].
  • Rheumatoid Arthritis (RA) and Lupus: These are systemic connective tissue diseases that can cause joint pain and fatigue [2][9].

Metabolic and Cardiovascular Health

Recent research has shown that the chronic inflammation associated with severe alopecia may have effects beyond the skin. Patients with AU may have an elevated risk for metabolic syndrome—a cluster of conditions including high blood pressure, high blood sugar, and abnormal cholesterol levels [10][11].

There is also evidence of a potential link between severe hair loss and an increased risk of cardiovascular disease [12][13]. It is important to understand that this is a relative risk—meaning it is slightly higher than the general population, but it does not mean you are guaranteed to have a heart attack. It simply means that your doctor should monitor your blood pressure and cholesterol during your routine check-ups to be proactive. This is especially true if you are starting systemic treatments like JAK inhibitors, which can sometimes cause changes in your lipid (cholesterol) levels [14][15].

Why Monitoring Matters

Because your immune system is currently in a state of high alert, monitoring for these other conditions is not about expecting the worst—it’s about early detection. Many of these related conditions, like thyroid disease, are highly treatable when caught early. Keeping a close eye on your overall health ensures that your care team is treating the whole person, not just the hair loss [16][17].

Common questions in this guide

Why do my nails look rough or pitted with Alopecia Universalis?
Nail changes happen because the immune system mistakenly targets the nails in the same way it targets hair follicles. Doctors often use symptoms like pitting or a rough texture, known as twenty-nail dystrophy, to gauge the severity of the autoimmune response.
Does having Alopecia Universalis increase my risk for other autoimmune diseases?
Yes, having Alopecia Universalis increases your risk for other autoimmune conditions because your immune system struggles to distinguish your own cells from foreign invaders. Common related conditions include Hashimoto's thyroiditis, vitiligo, and psoriasis.
Do I need to have my thyroid checked if I have severe alopecia?
Because the connection between Alopecia Universalis and autoimmune thyroid disease is very common, many specialists recommend regular screening. Your doctor will likely check your thyroid-stimulating hormone (TSH) and thyroid antibodies to catch any issues early.
Can severe hair loss affect my heart health?
Recent studies suggest that the chronic inflammation associated with severe alopecia may slightly increase the risk for metabolic syndrome and cardiovascular disease. Regular check-ups to monitor your blood pressure and cholesterol can help you proactively manage these risks.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Should I have my thyroid levels (TSH and T4) and thyroid antibodies (TPO) checked regularly?
  2. 2.Given my diagnosis, do I need a screening for celiac disease or other autoimmune digestive issues?
  3. 3.Are the changes I see in my nails definitely related to my alopecia, or should we look for other causes?
  4. 4.How should we monitor my cardiovascular health and cholesterol levels over time?
  5. 5.Are there specific symptoms of other autoimmune conditions I should be on high alert for?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Immunology of alopecia areata.

    Żeberkiewicz M, Rudnicka L, Malejczyk J

    Central-European journal of immunology 2020; (45(3)):325-333 doi:10.5114/ceji.2020.101264.

    PMID: 33437185
  2. 2

    Alopecia areata: descriptive analysis in a Brazilian sample.

    Lopes ASA, Santos LDN, Razé MC, Lazzarini R

    Anais brasileiros de dermatologia 2022; (97(5)):654-656 doi:10.1016/j.abd.2021.04.016.

    PMID: 35879180
  3. 3

    Nail Involvement in Alopecia Areata: A Questionnaire-based Survey on Clinical Signs, Impact on Quality of Life and Review of the Literature.

    Roest YBM, van Middendorp HT, Evers AWM, et al.

    Acta dermato-venereologica 2018; (98(2)):212-217 doi:10.2340/00015555-2810.

    PMID: 28967977
  4. 4

    Rare Presentation of Alopecia Universalis Congenita and Twenty-nail Dystrophy in Siblings.

    Mitra D, Agarwal R, Chopra A, Kandpal R

    International journal of trichology 2017; (9(2)):63-66 doi:10.4103/ijt.ijt_48_17.

    PMID: 28839389
  5. 5

    A Case of Idiopathic Twenty-Nail Dystrophy.

    Kumar R, Mujibur Rahman A, Umapathy N, et al.

    Cureus 2024; (16(9)):e70037 doi:10.7759/cureus.70037.

    PMID: 39449934
  6. 6

    Multiple Autoimmune Syndrome With Alopecia Universalis and Immune Thrombocytopenic Purpura.

    Alwasaidi TA, Mustafa W, Osman H, et al.

    Cureus 2021; (13(1)):e13033 doi:10.7759/cureus.13033.

    PMID: 33665054
  7. 7

    Understanding autoimmunity of vitiligo and alopecia areata.

    Rork JF, Rashighi M, Harris JE

    Current opinion in pediatrics 2016; (28(4)):463-9 doi:10.1097/MOP.0000000000000375.

    PMID: 27191524
  8. 8

    Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences.

    Yamaguchi HL, Yamaguchi Y, Peeva E

    International journal of molecular sciences 2024; (25(8)) doi:10.3390/ijms25084409.

    PMID: 38673994
  9. 9

    Polyglandular autoimmune syndrome type III with a prevalence of cutaneous features.

    Capo A, Amerio P

    Clinical and experimental dermatology 2017; (42(1)):61-63 doi:10.1111/ced.12984.

    PMID: 27859474
  10. 10

    Metabolic syndrome in patients with Alopecia Areata: A case-control study.

    Abdollahimajd F, Niknezhad N, Bahreini N, et al.

    Dermatologic therapy 2021; (34(4)):e14979 doi:10.1111/dth.14979.

    PMID: 33991033
  11. 11

    Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors.

    Sahin G, Aydin F, Pancar Yuksel E

    Journal of clinical medicine 2026; (15(1)) doi:10.3390/jcm15010396.

    PMID: 41517644
  12. 12

    Association between alopecia areata and cardiovascular disease: a systematic review and meta-analysis.

    Lu J, Cao X, Feng Y, et al.

    Frontiers in immunology 2025; (16()):1643709 doi:10.3389/fimmu.2025.1643709.

    PMID: 40852715
  13. 13

    Patients with alopecia areata are at risk of endothelial dysfunction: results of a case-control study.

    Waśkiel-Burnat A, Kotowska M, Dorobek W, et al.

    Clinical and experimental dermatology 2022; (47(8)):1517-1522 doi:10.1111/ced.15206.

    PMID: 35357040
  14. 14

    Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data.

    De Greef A, Thirion R, Ghislain PD, Baeck M

    Dermatology and therapy 2023; (13(11)):2869-2877 doi:10.1007/s13555-023-01030-x.

    PMID: 37717224
  15. 15

    Baricitinib as the first systemic treatment for severe alopecia areata.

    Kincaid CM, Arnold JD, Mesinkovska NA

    Expert review of clinical immunology 2023; (19(6)):565-573 doi:10.1080/1744666X.2023.2200166.

    PMID: 37042112
  16. 16

    Comparison of Current International Guidelines for the Management of Alopecia Areata-Comprehensive Review.

    Kropidłowska J, Kvinen A, Lewandowski M, et al.

    International journal of molecular sciences 2025; (26(17)) doi:10.3390/ijms26178632.

    PMID: 40943550
  17. 17

    European expert consensus statement on the systemic treatment of alopecia areata.

    Rudnicka L, Arenbergerova M, Grimalt R, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2024; (38(4)):687-694 doi:10.1111/jdv.19768.

    PMID: 38169088

This page provides educational information about health conditions associated with Alopecia Universalis. It is not intended as medical advice; always discuss your symptoms, nail changes, and screening needs with your healthcare provider.

Get notified when new evidence is published on Alopecia universalis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.